| Christian E Martin, MD | |
|
520 N Dekalb St Ste B, Shelby, NC 28150-4191 | |
| (704) 484-8001 | |
| (704) 484-2485 |
| Full Name | Christian E Martin |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 26 Years |
| Location | 520 N Dekalb St Ste B, Shelby, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346286366 | NPI | - | NPPES |
| 89126G9 | Medicaid | NC | |
| 1282M | Other | NC | BCBS OF NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 200100413 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kindred At Home | Shelby, NC | Home health agency |
| Atrium Health Cleveland | Shelby, NC | Hospital |
| Caromont Regional Medical Center | Gastonia, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Caromont Medical Group Inc | 3577476258 | 328 |
News Archive
Researchers at Monash University and Peter MacCallum Cancer Centre have identified for the first time how a new class of epigenetic drug engages with the immune system to kill off cancer cells, offering powerful new pathways for enhanced blood cancer therapies.
Lateral flow tests are more accurate than previously reported and cannot be compared directly to how PCR tests work, finds a new paper led by UCL researchers.
Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, today announced it has completed a $20 million round of Series C financing. Canaan Partners led the Series C round, which also included Pappas Ventures and Morningside Venture Investments Limited as new investors. Previous investors, including New Enterprise Associates and Firelake Capital, also participated in the financing round.
Pain medicine specialists at Rush have helped develop, and are among the first in the country to provide, a noninvasive treatment for knee arthritis that uses cooled radio energy to target and interrupt pain signals.
When cancer strikes, it may be possible for patients to fight back with their own defenses, using a strategy known as immunotherapy. According to a new study published in Nature, researchers have found a way to enhance the effects of this therapeutic approach in glioblastoma, a deadly type of brain cancer, and possibly improve patient outcomes.
› Verified 2 days ago
| Entity Name | Caromont Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356314272 PECOS PAC ID: 3577476258 Enrollment ID: O20031201000070 |
News Archive
Researchers at Monash University and Peter MacCallum Cancer Centre have identified for the first time how a new class of epigenetic drug engages with the immune system to kill off cancer cells, offering powerful new pathways for enhanced blood cancer therapies.
Lateral flow tests are more accurate than previously reported and cannot be compared directly to how PCR tests work, finds a new paper led by UCL researchers.
Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, today announced it has completed a $20 million round of Series C financing. Canaan Partners led the Series C round, which also included Pappas Ventures and Morningside Venture Investments Limited as new investors. Previous investors, including New Enterprise Associates and Firelake Capital, also participated in the financing round.
Pain medicine specialists at Rush have helped develop, and are among the first in the country to provide, a noninvasive treatment for knee arthritis that uses cooled radio energy to target and interrupt pain signals.
When cancer strikes, it may be possible for patients to fight back with their own defenses, using a strategy known as immunotherapy. According to a new study published in Nature, researchers have found a way to enhance the effects of this therapeutic approach in glioblastoma, a deadly type of brain cancer, and possibly improve patient outcomes.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christian E Martin, MD 520 N Dekalb St Ste B, Shelby, NC 28150-4191 Ph: (704) 484-8001 | Christian E Martin, MD 520 N Dekalb St Ste B, Shelby, NC 28150-4191 Ph: (704) 484-8001 |
News Archive
Researchers at Monash University and Peter MacCallum Cancer Centre have identified for the first time how a new class of epigenetic drug engages with the immune system to kill off cancer cells, offering powerful new pathways for enhanced blood cancer therapies.
Lateral flow tests are more accurate than previously reported and cannot be compared directly to how PCR tests work, finds a new paper led by UCL researchers.
Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, today announced it has completed a $20 million round of Series C financing. Canaan Partners led the Series C round, which also included Pappas Ventures and Morningside Venture Investments Limited as new investors. Previous investors, including New Enterprise Associates and Firelake Capital, also participated in the financing round.
Pain medicine specialists at Rush have helped develop, and are among the first in the country to provide, a noninvasive treatment for knee arthritis that uses cooled radio energy to target and interrupt pain signals.
When cancer strikes, it may be possible for patients to fight back with their own defenses, using a strategy known as immunotherapy. According to a new study published in Nature, researchers have found a way to enhance the effects of this therapeutic approach in glioblastoma, a deadly type of brain cancer, and possibly improve patient outcomes.
› Verified 2 days ago
Dr. George Lee Bradley, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 615 S Dekalb St, Shelby, NC 28150 Phone: 704-480-1882 Fax: 704-480-1832 | |
Dr. Robert Sandborn Perkins, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 808 Schenck St, Cleco Medical Center Of Shelby, Shelby, NC 28150 Phone: 704-484-3647 Fax: 704-471-2727 | |
Keturah Chesbrough Bell, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 708 Mcbrayer Homestead Rd, Shelby, NC 28152 Phone: 980-487-2090 | |
Tracy Lee Phelps, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1124 N Washington St, Shelby, NC 28150 Phone: 980-487-1148 | |
Dr. Julia K Roos, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 520 N Dekalb St, Shelby, NC 28150 Phone: 704-484-8001 Fax: 704-484-2485 | |
Dr. Kenneth Kyle Cloninger, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 808 Schenck St, Shelby, NC 28150 Phone: 704-480-9344 Fax: 704-484-3260 | |
Dr. Robert M Dorn, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 305 W College Ave, Shelby, NC 28152 Phone: 704-818-9200 |